|
Duloxetine Impurity 9
|
度洛西汀雜質(zhì)9
|
116539-57-2
|
|
Montelukast Impurity 17
|
孟魯司特雜質(zhì)17
|
1100617-38-6
|
|
rac-Duloxetine EP Impurity F HCl
|
消旋-度洛西汀 EP 雜質(zhì) F鹽酸鹽
|
1104890-90-5
|
|
Duloxetine Impurity A
|
度洛西汀雜質(zhì)A
|
947686-09-1
|
|
Montelukast Methyl Ester
|
孟魯司特甲酯
|
855473-51-7
|
|
Ibrutinib Impurity 1
|
依魯替尼雜質(zhì)1
|
1022150-11-3
|
|
Duloxetine EP Impurity D
|
度洛西汀EP雜質(zhì)D
|
90-15-3
|
|
Ibrutinib Impurity 13
|
依魯替尼雜質(zhì)13
|
1839099-22-7
|
|
Duloxetine EP Impurity B
|
度洛西汀EP雜質(zhì)B
|
116539-55-0
|
|
Duloxetine EP Impurity A HCl
|
度洛西汀EP雜質(zhì)A鹽酸鹽
|
910138-96-4
|
|
Ibrutinib (PCI-32765)
|
依魯替尼 (PCI-32765)
|
936563-96-1
|
|
Montelukast EP Impurity H
|
孟魯司特EP雜質(zhì)H
|
851755-56-1
|
|
(S)-Ibrutinib
|
(S)-依魯替尼
|
936563-97-2
|
|
Duloxetine EP Impurity E
|
度洛西汀EP雜質(zhì)E
|
1033803-59-6
|
|
Ibrutinib Impurity 10
|
依魯替尼雜質(zhì)10
|
2031255-23-7
|
|
Lacosamide Impurity 13
|
拉科酰胺雜質(zhì)13
|
201938-49-0
|
|
Lacosamide EP Impurity G
|
拉科酰胺EP雜G
|
588-46-5
|
|
Duloxetine Impurity 10
|
度洛西汀雜質(zhì)10
|
1346599-09-4
|
|
Ibrutinib Impurity 27
|
依魯替尼雜質(zhì)27
|
1288338-95-3
|
|
Montelukast Impurity 18
|
孟魯司特雜質(zhì)18
|
120578-04-3
|
|
Ibrutinib Impurity 28
|
依魯替尼雜質(zhì)28
|
2213398-75-3
|
|
Montelukast Methyl Ether
|
孟魯司特甲醚
|
|
|
Valsartan Impurity 32
|
纈沙坦雜質(zhì)32
|
1353844-77-5
|
|
Montelukast 1,2-Diol
|
孟魯司特1,2-二醇
|
186352-97-6
|
|
Lacosamide EP Impurity H (SR-Isomer)
|
拉考沙胺EP雜質(zhì)H
|
|
|
Montelukast EP Impurity A Sodium Salt
|
孟魯司特 EP 雜質(zhì) A 鈉鹽
|
190078-45-6
|
|
Montelukast Sulfone
|
孟魯司特砜
|
1266620-74-9
|
|
Montelukast R,S-Isomer
|
孟魯司特R,S-異構(gòu)體
|
1187586-58-8
|
|
N-Descarboxymethyl N-Carboxyethyl Lacosamide Impurity
|
N-脫羧甲基 N-羧乙基拉科酰胺雜質(zhì)
|
1318777-56-8
|
|
Montelukast Impurity 20
|
孟魯司特雜質(zhì)20
|
152922-71-9
|
|
Montelukast Impurity 8
|
孟魯司特雜質(zhì)8
|
30220-25-8
|
|
Lacosamide Impurity 12
|
拉考沙胺雜質(zhì)12
|
1375090-19-9
|
|
Lacosamide Impurity 6
|
拉考沙胺雜質(zhì)6
|
|
|
Duloxetine Impurity 8
|
度洛西汀雜質(zhì)8
|
132335-47-8
|
|
Lacosamide
|
拉考沙胺
|
175481-36-4
|
|
Montelukast Impurity 23
|
孟魯司特雜質(zhì)23
|
866923-64-0
|
|
Lacosamide Impurity A
|
拉科酰胺雜質(zhì)A
|
880468-89-3
|
|
Valsartan EP Impurity C;Valsartan USP Related Compound B
|
纈沙坦 EP 雜質(zhì) C；纈沙坦 USP 相關(guān)化合物 B
|
952652-79-8
|
|
Duloxetine Related Compound H
|
度洛西汀相關(guān)化合物H
|
199191-66-7
|
|
Montelukast Cyclopropacetaneamide Impurity
|
孟魯司特環(huán)丙酰胺雜質(zhì)
|
866923-63-9
|
|
Montelukast Keto Carbinol Impurity
|
孟魯司特酮醇雜質(zhì)
|
|
|
Duloxetine Impurity 15
|
度洛西汀雜質(zhì)15
|
940291-11-2
|
|
Duloxetine Impurity 7
|
度洛西汀雜質(zhì)7
|
763079-11-4
|
|
Lacosamide Impurity 11
|
拉考沙胺雜質(zhì)11
|
1695551-74-6
|
|
Lacosamide Impurity 2
|
拉科酰胺雜質(zhì)2
|
1600503-99-8
|
|
Duloxetine Impurity 12
|
度洛西汀雜質(zhì)12
|
116817-26-6
|
|
Montelukast Impurity 19
|
孟魯司特雜質(zhì)19
|
89729-09-9
|
|
Montelukast Impurity 2
|
孟魯司特雜質(zhì)2
|
149968-11-6
|
|
Montelukast Keto Impurity
|
孟魯司特酮雜質(zhì)
|
184764-13-4
|
|
Montelukast EP Impurity G
|
孟魯司特EP雜質(zhì)G
|
774538-96-4
|
|
Ibrutinib Impurity 18
|
依魯替尼雜質(zhì)18
|
1022150-12-4
|
|
Desacetyl Desmethyl Lacosamide
|
去乙酰去甲基拉科酰胺
|
175481-39-7
|
|
Ibrutinib Impurity 23
|
依魯替尼雜質(zhì)23
|
1917333-91-5
|
|
Lacosamide EP Impurity K
|
拉科酰胺EP雜K
|
86921-49-5
|
|
Ibrutinib Impurity 5
|
依魯替尼雜質(zhì)5
|
1288338-96-4
|
|
Lacosamide EP Impurity D HCl
|
拉科酰胺EP雜D HCl
|
1322062-76-9
|
|
Montelukast Impurity 6
|
孟魯司特雜質(zhì)6
|
1187586-63-5
|
|
N-Descarboxymethyl N-Ethyl Lacosamide Impurity
|
N-脫羧甲基N-乙基拉科酰胺雜質(zhì)
|
705283-63-2
|
|
Montelukast Sulfoxide Sodium
|
孟魯司特亞砜鈉
|
|
|
Duloxetine Related Compound J
|
度洛西汀相關(guān)化合物J
|
|
|
Ibrutinib Impurity ZY1
|
依魯替尼雜質(zhì)ZY1
|
|
|
Ibrutinib Impurity 7
|
依魯替尼雜質(zhì)7
|
143900-44-1
|
|
Montelukast Impurity 9
|
孟魯司特雜質(zhì)9
|
30430-40-1
|
|
Montelukast Diol Impurity
|
孟魯司特二醇雜質(zhì)
|
287930-77-2
|
|
Montelukast Impurity 3
|
孟魯司特雜質(zhì)3
|
150026-72-5
|
|
Montelukast Impurity I
|
孟魯司特雜質(zhì)I
|
|
|
Ibrutinib Impurity 6
|
依魯替尼雜質(zhì)6
|
1987905-93-0
|
|
Lacosamide EP Impurity C
|
拉科酰胺EP雜C
|
|
|
rac-Valsartan EP Impurity B
|
rac-纈沙坦 EP 雜質(zhì) B
|
1894176-44-3
|
|
Montelukast Impurity 7
|
孟魯司特雜質(zhì)7
|
|
|
Montelukast Impurity 4
|
孟魯司特雜質(zhì)4
|
142569-69-5
|
|
Duloxetine Impurity 2
|
度洛西汀雜質(zhì)2
|
|
|
Montelukast Chloro Alcohol Impurity
|
孟魯司特氯醇雜質(zhì)
|
880769-28-8
|
|
Duloxetine EP Impurity C HBr
|
度洛西汀EP雜質(zhì)C 溴化氫
|
949096-01-9
|
|
(S)-Duloxetine Phthalamide
|
(S)-度洛西汀鄰苯二甲酰胺
|
199191-67-8
|
|
Ibrutinib Impurity 8
|
依魯替尼雜質(zhì)8
|
330786-24-8
|
|
Ibrutinib Impurity 2
|
依魯替尼雜質(zhì)2
|
2031255-27-1
|
|
Duloxetine HCl
|
度洛西汀鹽酸鹽
|
136434-34-9
|
|
Montelukast Sodium Salt
|
孟魯司特鈉鹽
|
151767-02-1
|
|
Duloxetine EP Impurity G
|
度洛西汀EP雜質(zhì)G
|
321-38-0
|
|
Lacosamide EP Impurity A
|
拉科酰胺EP雜質(zhì)A
|
175481-37-5
|
|
Valsartan Methyl Ester
|
纈沙坦甲酯
|
137863-17-3
|
|
Duloxetine Impurity 14
|
度洛西汀雜質(zhì)14
|
178273-35-3
|
|
Montelukast Impurity 1
|
孟魯司特雜質(zhì)1
|
1258428-71-5
|
|
Lacosamide EP Impurity B
|
拉科酰胺EP雜B
|
1318777-54-6
|
|
Ibrutinib Impurity 3
|
依魯替尼雜質(zhì)3
|
1654820-87-7
|
|
Duloxetine Impurity 11
|
度洛西汀雜質(zhì)11
|
603996-87-8
|
|
Montelukast Dihydro Impurity
|
孟魯司特二氫雜質(zhì)
|
142147-67-9
|
|
Lacosamide EP Impurity J HCl
|
拉科酰胺EP雜J HCl
|
3287-99-8
|
|
Montelukast Bisolefin Impurity
|
孟魯司特雙烯烴雜質(zhì)
|
|
|
Duloxetine Impurity 1
|
度洛西汀雜質(zhì)1
|
|
|
4-Hydroxy Duloxetine Acetate
|
4-羥基度洛西汀醋酸鹽
|
662149-13-5
|
|
Valsartan EP Impurity A;Valsartan USP Related Compound A
|
纈沙坦 EP 雜質(zhì) A；纈沙坦 USP 相關(guān)化合物 A
|
137862-87-4
|
|
Lacosamide EP Impurity F
|
拉科酰胺EP雜F
|
175481-38-6
|
|
Montelukast Sulfone N-Oxide
|
孟魯司特砜N-氧化物
|
|
|
Ibrutinib Impurity 4
|
依魯替尼雜質(zhì)4
|
1807619-68-6
|
|
Montelukast Impurity 21
|
孟魯司特雜質(zhì)21
|
152922-72-0
|
|
Lacosamide EP Impurity I
|
拉科酰胺EP雜I
|
|
|
Duloxetine EP Impurity F HCl
|
度洛西汀EP雜質(zhì)F鹽酸鹽
|
2379325-42-3
|
|
Duloxetine Impurity 13
|
度洛西汀雜質(zhì)13
|
932013-45-1
|